Surgery, Gastroenterology and Oncology
Vol. 24, No. 3, Jun 2019
Combined Endoscopic Therapy And Percutaneous Approach in Patients with Biliary Strictures After Adult Right-Lobe Living-Donor Liver Transplantation
Horng-Ren Yang, Ashok Thorat, Wen-Hsin Huang, Cheng-Ju Yu, Te-Hung Chen, Shih-Chao Hsu, Kin-Shing Poon, Long-Bin Jeng
ORIGINAL PAPER, Jun 2019
Article DOI: 10.21614/sgo-24-3-136
Background: Endoscopic retrograde cholangiography (ERC) with balloon dilation and stenting is the curative treatment for biliary anastomotic (AS) strictures after living donor liver transplantation (LDLT). The aim of this study was to assess the technical feasibility and clinical outcomes of combined endoscopic and percutaneous therapy for biliary AS stricture in adult right-lobe living donor liver transplantation with duct to duct anastomosis.

Materials and methods: Between January 2008 and December 2015, 648 patients receiving right-lobe LDLT in our hospital were analyzed for biliary complications. When biliary strictures were diagnosed, patients underwent ERC first as a diagnostic as well as treatment modality to dilate the strictures and biliary stenting. If ERC failed, percutaneous transhepatic cholangiography (PTC) and or combined PTC and ERC were done.

Results: Eighty-two biliary strictures were diagnosed in 648 recipients (13%; 82 648) at an average of 256 (7-1979) days after LDLT. Among 82 patients (age 52.6 +- 9.6 years, range 24-72), 40 patients were successfully treated by ERC, 5 by PTC, and 9 by combined PTC and ERC. In successful ERC with an average of 5.03 +- 2.96 sessions, 11 +-11.0 plastic stents in total and 2+-1 stents at each ERC session were placed. The mean time to stricture resolution was 708 +- 532 (28-1967), 298 +- 135 (145-398), and 499 +- 239 (288-827) days for patients receiving ERC, PTC, and combined PTC and ERC, respectively.

Conclusions: Biliary complications following LDLT is associated with high mortality. In severe biliary strictures, the procedure that combines PTC and ERC can be curative in patients with prior failed ERC treatment.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 2893


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Dec 2024

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/